Rejuvitas is a New York-based company dedicated to mitigating neurodegeneration and age-related diseases through metabolic reprogramming. Founded in 2021, the company focuses on developing innovative solutions to address the underlying causes of neurodegenerative conditions, aiming to improve the quality of life for aging populations. Their market focus includes healthcare providers, research institutions, and individuals affected by these conditions.
Since its inception, Rejuvitas has made significant strides in the field of neurodegenerative disease research. The company's pioneering approach has garnered attention within the scientific community, contributing to advancements in understanding and treating age-related neurological disorders. Rejuvitas continues to impact the healthcare industry by pushing the boundaries of metabolic reprogramming and offering hope to those affected by these debilitating diseases.
